Summary & Overview
CPT 61510: Supratentorial Brain Tumor Resection, Bone Flap Craniotomy
CPT code 61510 identifies an open cranial procedure to remove a supratentorial brain tumor by creating a bone flap and excising the lesion. This code is used for non-meningioma tumors located above the tentorium cerebelli and is a key descriptor for neurosurgical operative reporting, utilization tracking, and hospital billing for intracranial tumor resections. Nationally, accurate use of this code affects surgical quality measurement, resource allocation for neurosurgical services, and payment determinations for high-acuity operative care.
Payors included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical framing of the procedure, the typical sites of service, commonly billed related codes, and the ICD-10 diagnostic contexts in which the code is applied. The publication also covers payer coverage patterns and common claim modifiers used in practice to reflect bilateral procedures, staged operations, professional vs. technical components, and unusual circumstances.
This summary equips billing managers, coding professionals, and clinical leaders with the operational context for 61510, highlights where coding precision matters for reimbursement and compliance, and situates the code within related cranial procedure codes for cross-reference.
Billing Code Overview
CPT code 61510 describes a neurosurgical procedure in which a portion of the skull (a bone flap) is removed to access and excise a brain tumor located above the tentorium cerebelli. The procedure specifically applies to supratentorial intracranial tumor excision and excludes operations performed for meningioma.
-
Service type: Open cranial tumor resection (supratentorial)
-
Typical site of service: Inpatient or outpatient hospital operating room, depending on clinical complexity and perioperative care needs
Clinical & Coding Specifications
Clinical Context
A 56-year-old right-handed patient presents with progressive headaches, focal weakness, and new-onset expressive aphasia. Preoperative MRI demonstrates a 3.5 cm supratentorial intra-axial mass within the left frontal lobe causing local mass effect and midline shift. Neurology and neurosurgery evaluate the patient; after multidisciplinary discussion, the decision is made to perform a craniectomy with removal of the tumor above the tentorium cerebelli. The typical workflow includes preoperative imaging (MRI with and without contrast, possible functional MRI and tractography), anesthesia evaluation, informed consent documenting risks including neurologic deficit, and operating room setup with neuronavigation and intraoperative neuromonitoring as indicated.
On the day of surgery the patient undergoes a bone flap craniotomy (craniectomy) with microsurgical excision of the supratentorial brain tumor. Intraoperative pathology (frozen section) may be obtained; adjuncts such as ultrasound, intraoperative MRI, or awake language mapping can be used when relevant. Postoperative care includes neuroimaging (noncontrast CT immediately post-op or MRI within 24–48 hours), neurologic monitoring in a neurosurgical step-down or intensive care unit, pain control, and early mobilization. Discharge planning addresses rehabilitation needs if residual neurologic deficits (for example R47.01 aphasia) persist, and outpatient oncology/neurosurgery follow-up is arranged for final pathology (benign D33.0, malignant C71.9, or uncertain behavior D43.0) and adjuvant therapy planning.
Coding Specifications
| Modifier |
|---|